Biofrontera quadruples shareholder base and increases trading volume
Biofrontera announced that its shareholder base has grown four-fold to about 1200 shareholders since the beginning of the year. At the same time the liquidity of the stock has greatly increased. Compared to the last months of the preceding year the recent daily trading was 10 to 20 times higher. Trading volumes in the five-digit range, which were exceptional last year, are now common. Even the trading of more than 100,000 shares per day has occasionally occurred without major movements of the stock price.
With the three capital increases that Biofrontera has, in spite of the difficult market conditions, been able to close this year, the company's share number increased to 7.6 mln. In parallel, the free-float grew to over 60%, such that the majority of the shares is now held by small funds and private investors.
"The significant expansion of the shareholder base and the increased liquidity of the stock reflect the positive development of Biofrontera's business. They serve as important benchmarks, which find strong attention when addressing investment groups," commented Werner Pehlemann, CFO of Biofrontera AG, the development.
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
